Coloplast Statistics
Total Valuation
Coloplast has a market cap or net worth of 25.21 billion. The enterprise value is 28.55 billion.
| Market Cap | 25.21B |
| Enterprise Value | 28.55B |
Important Dates
The last earnings date was Tuesday, February 4, 2025.
| Earnings Date | Feb 4, 2025 |
| Ex-Dividend Date | Dec 9, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.97% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 141.39M |
Valuation Ratios
The trailing PE ratio is 37.18.
| PE Ratio | 37.18 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.73, with an EV/FCF ratio of 115.73.
| EV / Earnings | 42.11 |
| EV / Sales | 7.42 |
| EV / EBITDA | 23.73 |
| EV / EBIT | 27.54 |
| EV / FCF | 115.73 |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.60.
| Current Ratio | 0.81 |
| Quick Ratio | 0.49 |
| Debt / Equity | 1.60 |
| Debt / EBITDA | 2.88 |
| Debt / FCF | 13.93 |
| Interest Coverage | 8.97 |
Financial Efficiency
Return on equity (ROE) is 31.94% and return on invested capital (ROIC) is 12.02%.
| Return on Equity (ROE) | 31.94% |
| Return on Assets (ROA) | 9.54% |
| Return on Invested Capital (ROIC) | 12.02% |
| Return on Capital Employed (ROCE) | 20.80% |
| Revenue Per Employee | 229,172 |
| Profits Per Employee | 40,775 |
| Employee Count | 16,639 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 2.48 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.72% in the last 52 weeks. The beta is 0.34, so Coloplast's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -13.72% |
| 50-Day Moving Average | 11.20 |
| 200-Day Moving Average | 12.44 |
| Relative Strength Index (RSI) | 46.15 |
| Average Volume (20 Days) | 166,110 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Coloplast had revenue of 3.81 billion and earned 678.01 million in profits. Earnings per share was 3.01.
| Revenue | 3.81B |
| Gross Profit | 2.57B |
| Operating Income | 1.03B |
| Pretax Income | 917.61M |
| Net Income | 678.01M |
| EBITDA | 1.15B |
| EBIT | 1.03B |
| Earnings Per Share (EPS) | 3.01 |
Balance Sheet
The company has 125.77 million in cash and 3.44 billion in debt, giving a net cash position of -3.31 billion.
| Cash & Cash Equivalents | 125.77M |
| Total Debt | 3.44B |
| Net Cash | -3.31B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.15B |
| Book Value Per Share | 9.53 |
| Working Capital | -333.03M |
Cash Flow
In the last 12 months, operating cash flow was 414.38 million and capital expenditures -167.70 million, giving a free cash flow of 246.69 million.
| Operating Cash Flow | 414.38M |
| Capital Expenditures | -167.70M |
| Free Cash Flow | 246.69M |
| FCF Per Share | n/a |
Margins
Gross margin is 67.45%, with operating and profit margins of 26.95% and 17.79%.
| Gross Margin | 67.45% |
| Operating Margin | 26.95% |
| Pretax Margin | 24.08% |
| Profit Margin | 17.79% |
| EBITDA Margin | 30.24% |
| EBIT Margin | 26.95% |
| FCF Margin | 6.47% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.80%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 1.80% |
| Dividend Growth (YoY) | 3.01% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 101.47% |
| Buyback Yield | -2.97% |
| Shareholder Yield | -1.16% |
| Earnings Yield | 2.69% |
| FCF Yield | 0.98% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Coloplast has an Altman Z-Score of 5.07.
| Altman Z-Score | 5.07 |
| Piotroski F-Score | n/a |